Processa Pharmaceuticals Correlations

PCSA Stock

USD 2.64 0.36 15.79%

The current 90-days correlation between Processa Pharmaceuticals and Entero Therapeutics is 0.01 (i.e., Significant diversification). The correlation of Processa Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Processa Pharmaceuticals Correlation With Market

Pay attention - limited upside

The correlation between Processa Pharmaceuticals and DJI is -0.78 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Processa Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Processa Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Processa Stock refer to our How to Trade Processa Stock guide.

Moving together with Processa Stock

0.63	OSE	OSE Pharma SA	Pair Corr
0.75	VCYT	Veracyte	Pair Corr
0.78	DRMA	Dermata Therapeutics	Pair Corr
0.88	DTIL	Precision BioSciences	Pair Corr

Moving against Processa Stock

0.79	EQ	Equillium	Pair Corr
0.73	GXEA	Galapagos NV	Pair Corr
0.58	8VP1	AVRICORE HEALTH INC	Pair Corr
0.52	VALN	Valneva SE ADR	Pair Corr
0.45	DNTH	Dianthus Therapeutics	Pair Corr
0.38	CMB	Cambium Bio	Pair Corr
0.82	DRTS	Alpha Tau Medical Earnings Call This Week	Pair Corr
0.77	0P6S	Bayer AG NA Earnings Call Tomorrow	Pair Corr
0.68	6C1	CytomX Therapeutics Earnings Call This Week	Pair Corr
0.56	DSGN	Design Therapeutics	Pair Corr
0.48	PYC	Physiomics Plc Earnings Call Tomorrow	Pair Corr
0.41	AVH	Avita Medical	Pair Corr
0.37	VERA	Vera Therapeutics	Pair Corr
0.36	DRUG	Bright Minds Biosciences	Pair Corr
0.7	VINC	Vincerx Pharma Common	Pair Corr
0.67	VNDA	Vanda Pharmaceuticals	Pair Corr
0.65	DVAX	Dynavax Technologies	Pair Corr
0.63	SRZNW	Surrozen Warrant	Pair Corr
0.6	ALA	Arovella Therapeutics	Pair Corr
0.4	HDP1	Arrowhead Pharmaceuticals	Pair Corr

Related Correlations Analysis

	BCTX	CRIS	ENTO	LPTX	PALI	HOTH	MBRX	ATHA	ALLR	CTXR
BCTX		0.63	0.11	-0.52	0.42	0.74	0.64	-0.68	0.52	0.84	BCTX
CRIS	0.63		0.4	-0.3	0.12	0.65	0.49	-0.42	0.15	0.68	CRIS
ENTO	0.11	0.4		-0.13	-0.38	-0.21	0.37	0.14	-0.42	0.24	ENTO
LPTX	-0.52	-0.3	-0.13		-0.31	-0.32	-0.29	0.46	-0.14	-0.44	LPTX
PALI	0.42	0.12	-0.38	-0.31		0.45	0.16	-0.6	0.45	0.33	PALI
HOTH	0.74	0.65	-0.21	-0.32	0.45		0.52	-0.59	0.71	0.76	HOTH
MBRX	0.64	0.49	0.37	-0.29	0.16	0.52		-0.18	0.47	0.77	MBRX
ATHA	-0.68	-0.42	0.14	0.46	-0.6	-0.59	-0.18		-0.33	-0.51	ATHA
ALLR	0.52	0.15	-0.42	-0.14	0.45	0.71	0.47	-0.33		0.59	ALLR
CTXR	0.84	0.68	0.24	-0.44	0.33	0.76	0.77	-0.51	0.59		CTXR
	BCTX	CRIS	ENTO	LPTX	PALI	HOTH	MBRX	ATHA	ALLR	CTXR

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CTXR	+ 0.84	BCTX
CTXR	+ 0.77	MBRX
CTXR	+ 0.76	HOTH
HOTH	+ 0.74	BCTX
ALLR	+ 0.71	HOTH
CTXR	+ 0.68	CRIS

High negative correlations

ATHA	- 0.68	BCTX
ATHA	- 0.6	PALI
ATHA	- 0.59	HOTH
LPTX	- 0.52	BCTX
CTXR	- 0.51	ATHA
CTXR	- 0.44	LPTX

Risk-Adjusted Indicators

There is a big difference between Processa Stock performing well and Processa Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Processa Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BCTX	6.08	(0.48)	0.00	(0.67)	0.00	0.00	10.18	(8.84)	98.43
CRIS	3.69	(0.08)	0.00	0.03	4.43	(4.93)	9.60	(7.83)	26.62
ENTO	7.46	(0.13)	0.00	(0.13)	0.00	0.00	16.86	(17.06)	39.61
LPTX	14.85	6.64	0.64	(11.78)	6.90	(21.69)	25.00	(9.43)	65.13
PALI	5.12	(0.17)	0.00	(0.67)	0.00	0.00	11.18	(10.26)	31.35
HOTH	2.79	(0.19)	0.00	(0.11)	0.00	0.00	6.17	(4.76)	14.39
MBRX	5.41	(1.75)	0.00	(0.71)	0.00	0.00	9.37	(11.73)	58.76
ATHA	4.12	0.49	0.10	1.03	4.10	(4.91)	6.70	(8.06)	71.83
ALLR	3.74	(0.15)	0.00	(0.50)	0.00	0.00	7.14	(7.29)	29.05
CTXR	4.36	(0.72)	0.00	(0.18)	0.00	0.00	10.59	(7.79)	37.83

Processa Pharmaceuticals Corporate Management

James Stanker	Chief Officer	Profile
PharmD Bigora	CoFounder Officer	Profile
Russell MBA	Chief Officer	Profile
Steven MD	Senior Research	Profile
Robert Floyd	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC